Press Releases & Presentations

Press Releases & Presentations

Date Title and Summary Additional Formats
Toggle Summary Accelerate Diagnostics to Review Second Quarter 2018 Results on August 6th
TUCSON, Ariz. , July 19, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Monday, August 6, 2018 to review the company’s second quarter 2018 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren , Read more
View HTML
Toggle Summary Accelerate Diagnostics to Present at the William Blair 38th Annual Growth Stock Conference
TUCSON, Ariz. , June 05, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today that Lawrence Mehren , President and Chief Executive Officer is scheduled to speak at the William Blair 38 th Annual Growth Stock Conference in Chicago, Illinois on Wednesday, June 13, 2018 at 2:40 PM, Read more
View HTML
Toggle Summary Accelerate Diagnostics reports Q1 2018 financial results
TUCSON, Ariz. , May 09, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced financial results for the quarter ending March 31 , 2018.  The company generated revenue of $801,000 , up 51% from the prior year, and reported signed agreements for 345 instruments. Read more
View HTML
Toggle Summary Accelerate Diagnostics to Review First Quarter 2018 Results on May 9th
TUCSON, Ariz. , April 30, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today it will host a conference call on Wednesday, May 9, 2018 to review its first quarter 2018 financial results and commercial progress. President and Chief Executive Officer, Lawrence Mehren , joined by Read more
View HTML
Toggle Summary Accelerate Diagnostics announces sizeable release of new data at ECCMID 2018
Four integrated symposium sessions, 11 poster presentations, and case studies will cover the clinical value of integrating diagnostic stewardship into current sepsis protocols given the rising rates of antibiotic resistance TUCSON, Ariz. , April 21, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Read more
View HTML
Toggle Summary Accelerate Diagnostics, Inc. Announces Pricing of $150 Million Convertible Notes Offering
TUCSON, Ariz. , March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“ Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount of 2.50% convertible senior notes due 2023 (the “notes”) in a private placement to qualified Read more
View HTML
Toggle Summary Accelerate Diagnostics Inc. Announces $150 Million Convertible Notes Offering
TUCSON, Ariz. , March 22, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced its intention to offer, subject to market conditions and other factors, $150.0 million aggregate principal amount of convertible senior notes due 2023 (the “notes”) in a private placement Read more
View HTML
Toggle Summary Accelerate Diagnostics reports Q4 and Full-Year Financial Results for 2017
TUCSON, Ariz. , Feb. 15, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. today announced preliminary full-year 2017 financial results including the quarter ending December 31, 2017 . The company reported revenue for Q4 of $2.1 million , doubling revenue for the year, and signed agreements for Read more
View HTML
Toggle Summary Accelerate Diagnostics to Host Q4 and Full-Year 2017 Earnings Call on February 15, 2018
TUCSON, Ariz. , Feb. 08, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. will host a conference call on Thursday, February 15, 2018 to review its fourth quarter and full-year financial results for 2017. President and Chief Executive Officer, Lawrence Mehren , joined by Steve Reichling , Chief Read more
View HTML
Toggle Summary Accelerate Diagnostics achieves CE-IVD milestone for severe bacterial pneumonia assay, doubles revenue for 2017 in Q4
TUCSON, Ariz. , Jan. 10, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. announced today its declaration of conformity to the European In Vitro Diagnostic Directive 98/79/EC and CE mark of its latest assay for the Accelerate Pheno™ system targeting severe bacterial pneumonia infections. Read more
View HTML
:

Day High:
Day Low:  
Volume:    

Copyright Nasdaq. Minimum 15 minutes delayed.


Want to receive investor-related news and updates?

Join our mailing list

Other updates